Stockscreener 앱 받기
2.11
7.86%
-0.18
InspireMD Inc. 주식(NSPR)의 최신 뉴스
Earnings call transcript: InspireMD Q3 2025 beats EPS expectations By Investing.com - Investing.com Philippines
Earnings call transcript: InspireMD Q3 2025 beats EPS expectations - Investing.com
InspireMD’s Sales Jump Thanks To Its Flagship Stent Launch - Finimize
InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
InspireMD, Inc. Q3 Loss Increases, But Beats Estimates - Nasdaq
InspireMD Reports Third Quarter 2025 Financial Results - The Manila Times
InspireMD Reports Third Quarter 2025 Financial Results - GlobeNewswire Inc.
Why analysts remain bullish on InspireMD Inc. stockTrade Risk Report & Daily Price Action Insights - newser.com
Using data filters to optimize entry into InspireMD Inc.2025 Price Action Summary & Weekly High Return Forecasts - newser.com
Applying chart zones and confluence areas to InspireMD Inc.July 2025 Selloffs & Low Drawdown Investment Strategies - newser.com
Analyzing InspireMD (NYSE:NSPR) & Acutus Medical (NASDAQ:AFIB) - Defense World
InspireMD appoints Dr. Peter Soukas as chief medical officer By Investing.com - Investing.com Nigeria
InspireMD, Inc. Appoints Peter A. Soukas, M.D., as Chief Medical Officer - MarketScreener
Cardiologist Peter Soukas becomes chief medical officer of carotid stent company - Cardiovascular Business
Why InspireMD Inc. (II2) stock remains top ratedQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Is InspireMD Inc. stock poised for growth2025 Year in Review & Stock Portfolio Risk Control - newser.com
InspireMD appoints Dr. Peter Soukas as chief medical officer - Investing.com
InspireMD Appoints Dr. Peter A. Soukas as Chief Medical Officer to Advance Carotid Intervention Initiatives - Quiver Quantitative
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer - The Manila Times
InspireMD (NASDAQ: NSPR) names Dr. Peter Soukas CMO as CGuard Prime launches in U.S. - Stock Titan
How InspireMD Inc. stock reacts to Fed rate cuts2025 Big Picture & Scalable Portfolio Growth Methods - newser.com
Can InspireMD Inc. stock weather global recessionMarket Activity Report & AI Driven Stock Reports - newser.com
How risky is InspireMD Inc. (II2) stock compared to peersWeekly Stock Recap & High Accuracy Buy Signal Tips - newser.com
What to do if you’re stuck in InspireMD Inc.Market Sentiment Report & AI Forecast for Swing Trade Picks - newser.com
Short interest data insights for InspireMD Inc.Trade Entry Report & Weekly Setup with ROI Potential - newser.com
Can InspireMD Inc. (II2) stock attract ESG investmentsTrade Exit Summary & Proven Capital Preservation Tips - newser.com
Backtesting results for InspireMD Inc. trading strategiesQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
What margin trends mean for InspireMD Inc. stockWeekly Stock Report & Community Consensus Stock Picks - newser.com
How InspireMD Inc. (II2) stock responds to job market shiftsEarnings Miss & Technical Entry and Exit Alerts - newser.com
How strong dollar benefits InspireMD Inc. (II2) stockJuly 2025 Catalysts & Reliable Momentum Entry Alerts - newser.com
How InspireMD Inc. (II2) stock reacts to stronger dollar2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
InspireMD Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Pleasing Signs As A Number Of Insiders Buy InspireMD Stock - Yahoo Finance
Is InspireMD Inc. stock a defensive play in 2025July 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
0.82%
자본화:
|
볼륨(24시간):